Levetiracetam 1a Farma

Levetiracetam, the active ingredient in Lelevetiracetam 1a Farma, is an anticonvulsant presented as an oral tablet for oral use. It is prescribed to manage various seizure types in patients with epilepsy and works across a broad age range as part of individualized treatment plans.

GNH USA supplies Levetiracetam 1a Farma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance for global healthcare providers.

Levetiracetam is used to treat seizure disorders by stabilizing neuronal activity.

- Partial seizures: reduces the frequency of focal onset seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes. - Myoclonic seizures: decreases sudden muscle jerks associated with epilepsy.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: transient feeling of light‑headedness. - Somnolence: increased sleepiness or fatigue. - Headache: mild to moderate cranial pain. - Irritability: mood changes or agitation. - Nausea: occasional stomach upset.

Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Severe allergic reactions: including anaphylaxis. - Blood disorders: rare cases of leukopenia or thrombocytopenia. - Multi‑organ hypersensitivity: systemic inflammatory response.

When prescribing levetiracetam, clinicians should consider several precautionary measures to ensure patient safety.

- Renal function: adjust dose in patients with impaired kidney function. - Pregnancy: Category B; discuss potential risks and benefits with the patient. - Concomitant CNS depressants: monitor for enhanced sedation. - Psychiatric symptoms: observe for mood changes or depression. - Alcohol: advise avoidance of excessive consumption. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenobarbital: can reduce levetiracetam levels. - Phenytoin: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, alcohol): increased sedation risk. - Antidepressants (SSRIs): monitor for mood alterations. - Vaccines: potential impact on immune response; observe patient closely.